Not all clients with CLL need therapy. Even with all latest advancements, the iwCLL continue to recommends watchful observation for sufferers with asymptomatic sickness.86 This suggestion is predicated on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Di segmen ini, https://fredr776eti3.wikififfi.com/user